♫musicjinni

Evaluating the Health Impacts of Medicinal Cannabinoid Use - Heather Jackson

video thumbnail
Tags: Cannabidiol, Epilepsy, Doose Syndrome, Autism, Neurology

Heather Jackson

After Heather Jackson’s son journeyed from hospice to health using cannabis she co-founded and is the CEO of Realm of Caring a national acclaimed nonprofit that aids families with life-limiting conditions that are using cannabis and hemp along with educating practitioners on practical day-to-day applications of cannabis for their patients. Over two years ago they started an observational research registry with Johns Hopkins University and the University of Pennsylvania to track the population they serve. This talk will describe the data from the registry regarding the epilepsy population. If you have wondered what is actually happening with the use of whole plant botanical products for epilepsy, you do not want to miss this abstract discussion. Learn more about health outcomes, quality of life, economic impact, side effects and more. Discover both quantitative and qualitative analysis of the epilepsy population that the Realm of Caring serves.

CannMed 2019 keynote Dr. David Meiri promotes the value of cannabis science conferences

CannMed 2018 to Showcase Greatest Minds in Cannabis Research

CannMed 2019 - Dr. Mechoulam on Educating Cannabis Cultivators

Raphael Mechoulam Previews CannMed 2019 Keynote Presentation

New Insights in the Cannabis Genome will Be Shared at CannMed 2018

Crypto-Funded Cannabis Genomes - Kevin McKernan

The Endocannabinoid System – A Source for Drug Discovery - Alexandros Makriyannis

Endocannabinoid System: A Fifty Year Trip - Raphael Mechoulam

Jonathan Page - Elucidating Cannabinoid Biosynthesis Using Trichome Targeted Genomics | CannMed 2017

Dr. Raphael Mechoulam Speaks to the Diversity of CannMed Attendees

How to Legally Recommend Cannabis to your Patients - Valerio Romano, Michael Cutler, Bonni Goldstein

Cannabis Used in Research Does Not Reflect Legal Markets - Nolan Kane

Matching an effective cannabis strain extract for a specific subtype of cancer - David Meiri

Cannabis Contaminants: Practical Considerations vs. Regulatory Requirements - Christopher Hudalla

Cannabis for Pain Management and Opioid Use Reduction - Jordan Tishler

Reefer Revolution LIVE! CannMed 2019 Sunset Welcome Reception

Israel, Leading a Process: From Illegal Substance to Potent Medication - Michael Dor

Reefer Revolution LIVE! CannMed 2019 #cannmed2019 Day 1

Potential clinical benefits of CBD enriched extracts over purified CBD... - Fabricio Pamplona

Treating Cancer with Cannabis-Derived Flavonoids with Akeem Gardner

Women’s Health and Cannabis - Panel Presentation

A Note From Dr. Mechoulam | CannMed 2017

Making a Difference: Exploring the Science of Medicinal Cannabis

Reviewing Research on Cannabis and COVID-19 with Ethan Russo, MD

Evaluating the Health Impacts of Medicinal Cannabinoid Use - Heather Jackson

Investing in Cannabis Innovation with David Traylor

Grand Unified Theory: The Endocannabinoid System, Cannabis and the Microbiome - Ethan Russo, MD

Leveraging Influence to Promote Medical Cannabis - Panel Presentation

The Anti-Cancer Activity of Cannabinoids Against Ovarian Cancer Involves the WNT Pathway - Hinanit K

Therapeutic Potential of Cannabis for Alzheimer’s Disease - Panel Presentation

Disclaimer DMCA